|
1
|
Delmonte A, Bonanno L, Landi L, Andrikou K, Dal Maso A, Minuti G, Papi M, Metro G, Attili I, Piantedosi F, Pilotto S, Gori S, Rossi G, Buglioni S, Giannarelli D, Cappuzzo F. EP08.01-030 Nivolumab+Ipilimumab Vs Platinum-Based CT+Nivolumab In Advanced Lung Squamous-Cell Carcinoma: The Randomized SQUINT Trial. J Thorac Oncol 2022. [DOI: 10.1016/j.jtho.2022.07.602] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
|
2
|
Cappuzzo F, Delmonte A, Landi L, Andrikou K, Dal Maso A, Minuti G, Lee C, Wang X, Papi M, Metro G, Attili I, Piantedosi F, Pilotto S, Gori S, Rossi G, Buglioni S, Giannarelli D, Bonanno L. 1048P Molecular predictors of immunotherapy efficacy in lung squamous-cell carcinoma (LSCC): Results from the randomized prospective SQUINT trial. Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.07.1174] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
|
3
|
Olivero F, Franco P, Ferreri F, Gardini AC, Andrikou K, Arcadipane F, Gastino A, De Luca V, Cascinu S, Ricardi U. PO-0806: Prognostic value of eosinophil levels in oropharyngeal cancer: a retrospective multicentric study. Radiother Oncol 2020. [DOI: 10.1016/s0167-8140(21)00823-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
|
4
|
Pecora I, Vivaldi C, Rovesti G, Catanese S, Salani F, Gardini AC, Massa V, Bernardini L, Riggi M, Andrikou K, Rapposelli I, Formica V, Cesario S, Caccese M, Lencioni M, Vasile E, Falcone A, Fornaro L. P-188 Safety and efficacy of first-line gemcitabine plus nab-paclitaxel for elderly metastatic pancreatic cancer patients. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.04.270] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
|
5
|
Salati M, Pipitone S, Rimini M, Gelsomino F, Casadei-Gardini A, Andrikou K, Schipilliti F, Cortesi G, Cassanelli L, Caffari E, Serra F, Ricciardolo A, De Ruvo N, Gelmini R, Cascinu S, Spallanzani A. A user-friendly nomogram to predict relapse-free survival (RFS) in western patients with resected gastric cancer (GC). Ann Oncol 2019. [DOI: 10.1093/annonc/mdz247.107] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
|
6
|
Caputo F, Salati M, Cerma K, Spallanzani A, Andrikou K, Gelsomino F, Orsi G, Rovesti G, Riggi M, Molinaro E, Santini C, Bardasi C, Rimini M, Pipitone S, Cortesi G, Schipilliti F, Canino F, Casadei-gardini A, Cascinu S. The prognostic nutritional index (PNI) is an independent predictor of survival in advanced biliary cancers (ABC) receiving first-line chemotherapy (1L). Ann Oncol 2019. [DOI: 10.1093/annonc/mdz247.066] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
|
7
|
Vivaldi C, Ugolini C, Orsi G, Formica V, Catanese S, Andrea C, Andrikou K, Doldo E, Pecora I, Campani D, Bonetti LR, Pasquini G, Salani F, Massa V, Niccoli C, Lencioni M, Vasile E, Gardini AC, Fornaro L, Fontanini G, Cascinu S, Falcone A. Characterization of mismatch repair deficiency in biliary tract cancer. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz155.278] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
|
8
|
Ziranu P, Lai E, Casadei Gardini A, Pretta A, Faloppi L, Andrikou K, Astara G, Orsi G, Impera V, Mariani S, Liscia N, Soro P, Musio F, Camera S, Tolu S, Madeddu C, Massa E, Pusceddu V, Demurtas L, Puzzoni M, Cascinu S, Scartozzi M. A new prognostic score for biliary tract cancer: a multicenter experience. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz155.331] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
|
9
|
Salati M, Pipitone S, Rimini M, Gelsomino F, Gardini AC, Andrikou K, Schipilliti F, Cortesi G, Cassanelli L, Caffari E, Serra F, Ricciardolo A, De Ruvo N, Gelmini R, Cascinu S, Spallanzani A. Immune-inflammatory and clinicopathologic prognostic factors in a Western cohort of resected gastric cancers (GCs). Ann Oncol 2019. [DOI: 10.1093/annonc/mdz155.274] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
|
10
|
Rovesti G, Orsi G, Faloppi L, Gramantieri L, Silvestris N, Marisi G, Foschi F, Tamburini E, Andrikou K, Molinaro E, Riggi M, Scartozzi M, Cascinu S, Gardini AC. Sorafenib in patients with hepatocellular carcinoma: 10 years of real life. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz155.208] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
|
11
|
Franco P, Montagnani F, Arcadipane F, Casadei C, Andrikou K, Franco G, Scartozzi M, Mistrangelo M, Fornaro L, Cassoni P, Cascinu S, Ricardi U, Casadei Gardini A. Immune Inflammation Indicators Predict Outcome in Anal Cancer Patients Undergoing Concurrent Chemoradiation. Int J Radiat Oncol Biol Phys 2018. [DOI: 10.1016/j.ijrobp.2018.07.204] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
|
12
|
Orsi G, Andrikou K, Bergamo F, Nappo F, Manai C, Passardi A, Puzzoni M, Vallarelli S, Libertini M, Riggi M, Pugliese G, Zaniboni A, Schirripa M, Procaccio L, Silvestris N, Scartozzi M, Casadei Gardini A, Zagonel V, Cascinu S. The role of adjuvant therapy in resectable SBA: A different clinicians attitude with a relevant impact on outcome. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy282.157] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
|
13
|
Rimini M, Bardasi C, Gelsomino F, Andrikou K, Santini C, Orsi G, Salati M, Riggi M, Pipitone S, Cascinu S, Spallanzani A. The role of primary tumour location in the recurrence rate of metachronous metastasis of colon cancer. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy281.134] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
|
14
|
Salati M, Caputo F, Spallanzani A, Rimini M, Gelsomino F, Andrikou K, Cascinu S. A novel immune-inflammatory score to predict survival in patients (pts) with advanced biliary tract cancer (ABTC) receiving first-line chemotherapy (1-line cht). Ann Oncol 2018. [DOI: 10.1093/annonc/mdy282.153] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
|
15
|
Franco P, Montagnani F, Arcadipane F, Casadei C, Andrikou K, Martini S, Iorio G, Scartozzi M, Mistrangelo M, Fornaro L, Cassoni P, Cascinu S, Ricardi U, Casadei Gardini A. EP-1461: Immune inflammation indicators in anal cancer patients treated with concurrent chemo-radiation. Radiother Oncol 2018. [DOI: 10.1016/s0167-8140(18)31770-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
|
16
|
Martini S, Iorio G, Franco P, Montagnani F, Arcadipane F, Casadei C, Andrikou K, Scartozzi M, Mistrangelo M, Fornaro L, Cassoni P, Cascinu S, Ricardi U, Casadei Gardini A. EP-1487: The prognostic role of haemoglobin in patients undergoing concurrent chemo-radiation for anal cancer. Radiother Oncol 2018. [DOI: 10.1016/s0167-8140(18)31796-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
|
17
|
Spallanzani A, Gelsomino F, Caputo F, Salati M, Reggiani Bonetti L, Domati F, Andrikou K, Fontana A, Di Emidio K, Baldessari C, Pugliese G, Bettelli S, Luppi G, Cascinu S. The prognostic impact of sidedness across all stages during the last 20 years: the “Modena Cancer Registry” experience. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx422.022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
|
18
|
Andrikou K, Bittoni A, Giampieri R, Pugliese G, Orsi G, Barbolini M, Lanese A, Berardi R, Cascinu S. Small bowel adenocarcinoma (SBA) is a rare and heterogeneous disease: results of a retrospective analysis. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx425.023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
|
19
|
Baldessari C, Spallanzani A, Gelsomino F, Bettelli S, Pugliese G, Salati M, Caputo F, Andrikou K, Fontana A, Di Emidio K, Napolitano M, Kaleci S, Luppi G, Cascinu S. Outcome and prognostic factors after resection of liver metastases in patients with colorectal cancer. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx422.036] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
|
20
|
Del Prete M, Faloppi L, Casadei Gardini A, Santini D, Silvestris N, Bianconi M, Giampieri R, Bittoni A, Andrikou K, Valgiusti M, Brunetti O, Scartozzi M, Cascinu S. LDH serum levels as prognostic and predictive factor in advanced biliary tract cancer patients treated with first line chemotherapy. Ann Oncol 2015. [DOI: 10.1093/annonc/mdv344.33] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
|
21
|
Faloppi L, Casadei Gardini A, Masi G, Silvestris N, Loretelli C, Ulivi P, Vivaldi C, Bianconi M, Giampieri R, Bittoni A, Andrikou K, Del Prete M, Gadaleta C, Scartozzi M, Cascinu S. Angiogenesis polymorphisms profile in the prediction of clinical outcome of advanced HCC patients receiving sorafenib: combined analysis of VEGF and HIF-1a. Final results of the ALICE-2 study. Ann Oncol 2015. [DOI: 10.1093/annonc/mdv344.04] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
|
22
|
Bittoni A, Andrikou K, Santoni M, Giampieri R, Mandolesi A, Pellei C, Faloppi L, Loretelli C, Lanese A, Del Prete M, Maccaroni E, Bianconi M, Cascinu S. Mismatch repair protein expression and Hedgehog signalling pathways in human pancreatic cancer. Ann Oncol 2015. [DOI: 10.1093/annonc/mdv344.09] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
|
23
|
Bianconi M, Faloppi L, Mazzucchelli R, Giampieri R, Bittoni A, Del Prete M, Andrikou K, Montironi R, Cascinu S. Multigene profiling in incidentally- and clinically detected prostate cancer. Ann Oncol 2015. [DOI: 10.1093/annonc/mdv341.25] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
|
24
|
Giampieri R, Del Prete M, Faloppi L, Bianconi M, Andrikou K, Bittoni A, Maccaroni E, Cascinu S. Role of different toxicity profile on outcome for colorectal cancer patients receiving Regorafenib monotherapy. Ann Oncol 2015. [DOI: 10.1093/annonc/mdv340.42] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
|
25
|
Bianconi M, Faloppi L, Zizzi A, Mazzucchelli R, Giampieri R, Bittoni A, Andrikou K, Del Prete M, Scartozzi M, Montironi R, Cascinu S. 2580 Multigene profiling in incidentally- and clinically detected prostate cancer. Eur J Cancer 2015. [DOI: 10.1016/s0959-8049(16)31399-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
|
26
|
Faloppi L, Del Prete M, Casadei Gardini A, Santini D, Silvestris N, Bianconi M, Giampieri R, Bittoni A, Andrikou K, Valgiusti M, Brunetti O, Scartozzi M, Cascinu S. 2390 LDH serum levels as prognostic and predictive factor in advanced biliary tract cancer patients treated with first line chemotherapy. Eur J Cancer 2015. [DOI: 10.1016/s0959-8049(16)31306-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
|
27
|
Del Prete M, Giampieri R, Faloppi L, Bianconi M, Bittoni A, Andrikou K, Cascinu S. Panitumumab for the treatment of metastatic colorectal cancer: a review. Immunotherapy 2015; 7:721-38. [PMID: 26250414 DOI: 10.2217/imt.15.46] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022] Open
Abstract
In recent years, the treatment of metastatic colorectal cancer (mCRC) has evolved significantly with the increase of new therapeutic options, leading to an improved median survival for these patients. In particular, the identification of molecular targets in tumor cells has led to the introduction of biological drugs for the treatment of mCRC. Panitumumab is a fully human monoclonal antibody that binds the EGF receptor of tumor cells and inhibits downstream cell signaling with antitumor effect on inhibition of tumor growth. Its use has been approved by randomized clinical trials as monotherapy in chemorefractory patients or combined with chemotherapy in the treatment of RAS wild-type mCRC, where it demonstrated a significant improvement in survival and response rate. The purpose of this review is to analyze the use and efficacy profile of panitumumab, particularly focusing on recently reported data on its use, and future perspectives in patients with mCRC.
Collapse
Affiliation(s)
- M Del Prete
- Medical Oncology, AOU Ospedali Riuniti-Università Politecnica delle Marche, via Conca 71, 60126 Ancona, Italy
| | - R Giampieri
- Medical Oncology, AOU Ospedali Riuniti-Università Politecnica delle Marche, via Conca 71, 60126 Ancona, Italy
| | - L Faloppi
- Medical Oncology, AOU Ospedali Riuniti-Università Politecnica delle Marche, via Conca 71, 60126 Ancona, Italy
| | - M Bianconi
- Medical Oncology, AOU Ospedali Riuniti-Università Politecnica delle Marche, via Conca 71, 60126 Ancona, Italy
| | - A Bittoni
- Medical Oncology, AOU Ospedali Riuniti-Università Politecnica delle Marche, via Conca 71, 60126 Ancona, Italy
| | - K Andrikou
- Medical Oncology, AOU Ospedali Riuniti-Università Politecnica delle Marche, via Conca 71, 60126 Ancona, Italy
| | - S Cascinu
- Medical Oncology, AOU Ospedali Riuniti-Università Politecnica delle Marche, via Conca 71, 60126 Ancona, Italy
| |
Collapse
|
|
28
|
Pellei C, Bittoni A, Andrikou K, Lanese A, Santoni M, Conti A, Aroldi F, Delcuratolo S, Russano M, Vaccaro V, Silvestris N, Milella M, Santini D, Zaniboni A, Cascinu S. Single-Agent or Doublets As Second-Line Chemotherapy After Folfirinox in Patients with Locally Advanced or Metastatic Pancreatic Cancer. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu334.94] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
|
29
|
Santoni M, Bittoni A, Andrikou K, Lanese A, Pellei C, Conti A, Bertocchi P, Brunetti A, Russano M, Vaccaro V, Silvestris N, Milella M, Santini D, Zaniboni A, Cascinu S. Does First-Line Therapy Affect the Outcome of Patients with Pancreatic Cancer? Ann Oncol 2014. [DOI: 10.1093/annonc/mdu334.80] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
|
30
|
Conti A, Santoni M, Bittoni A, Andrikou K, Lanese A, Pellei C, Loretelli C, Mandolesi A, Alfonsi S, Scarpelli M, Cascinu S. Cox-2 Status Modulates the Activation of Hedgehog Pathway and Consequently the Expression of Stem Cell Markers in Patients with Pancreatic Ductal Adenocarcinoma. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu334.83] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
|
31
|
Andrikou K, Bittoni A, Lanese A, Santoni M, Pellei C, Conti A, Aroldi F, Brunetti A, Russano M, Vaccaro V, Silvestris N, Milella M, Santini D, Zaniboni A, Cascinu S. Who Should Receive First-Line Folfirinox? Prognostic Factors in Locally Advanced or Metastatic Pancreatic Cancer Patients. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu334.88] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
|
32
|
Lanese A, Bittoni A, Santoni M, Andrikou K, Pellei C, Conti A, Bertocchi P, Brunetti A, Russano M, Vaccaro V, Silvestris N, Milella M, Santini D, Zaniboni A, Cascinu S. Clinical Outcome of Elderly (>70Y) Advanced Pancreatic Cancer Patients Receiving Chemotherapy. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu334.95] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
|
33
|
Bittoni A, Andrikou K, Lanese A, Santoni M, Pellei C, Conti A, Mandolesi A, Alfonsi S, Scarpelli M, Cascinu S. Her Family Receptor Expression and Clinical Outcome in Pancreatic Cancer Patients. Ann Oncol 2014. [DOI: 10.1093/annonc/mdu334.91] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|